Amryt Pharma (AMYT)
Amryt Pharma is a specialty biopharmaceutical company focused on developing and delivering innovative new treatments to help improve the lives of patients with rare or orphan diseases. The Company is building a diversified portfolio of commercially attractive, best-in-class, proprietary new drugs to help address some of these rare and debilitating illnesses for which there are currently no available treatments.
Mercia Asset Management (MERC)
Mercia is a proactive, specialist asset manager focused on supporting regional SMEs to achieve their growth aspirations. Mercia provides capital across its four asset classes of balance sheet, venture, private equity and debt capital; the Group's 'Complete Capital Solution'. The Group initially nurtures businesses via its third-party funds under management, then over time Mercia can provide further funding to the most promising companies, by deploying direct investment follow-on capital from its own balance sheet.
Surface Transforms (SCE)
Surface Transforms are experts in the development and production of carbon-ceramic materials and the UK’s only manufacturer of carbon-ceramic brakes for automotive use. ST utilises our proprietary next-generation carbon-ceramic material - CCST - to create lightweight brake discs for high-performance applications, including automotive and aircraft brakes. Surface Transforms has extensive in-house engineering and manufacturing capabilities, including the facilities for manufacturing carbon-ceramic brake discs.